Day One Biopharmaceuticals, Inc vs Pfizer, Inc. — Stock Comparison

DAWN
Day One Biopharmaceuticals, Inc
$21.53
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.5/10

Q·Score Breakdown

4.5
Bearish
Overall
6.5
Neutral
0.5
Quality
7.4
9.2
Health
7
7.3
Growth
5.6
3.7
Valuation
6.7
2.5
Sentiment
5.2
DAWN

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-68% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $21.50 (-0.1%)
6 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

DAWN
PFE
Trailing P/E
19.4×
-112.4×
Forward P/E
9.4×
-67.8%
Profit Margin
12.4%
89.1%
Gross Margin
75.8%
-22.7%
ROE
8.9%
83.9%
Revenue Growth
-1.2%
Earnings Growth
-1.75
Beta
0.39
Price / Book
$2.2B
Market Cap
$149.8B
$6 – $22
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →